Suzhou Historical Income Statement
| 688137 Stock | 37.25 0.32 0.87% |
Historical analysis of Suzhou Novoprotein income statement accounts such as Interest Income of 32 M, Interest Expense of 2.9 M or Selling General Administrative of 55.3 M can show how well Suzhou Novoprotein Scientific performed in making a profits. Evaluating Suzhou Novoprotein income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Suzhou Novoprotein's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Suzhou Novoprotein latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Suzhou Novoprotein is a good buy for the upcoming year.
Suzhou |
About Suzhou Income Statement Analysis
Suzhou Novoprotein Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Suzhou Novoprotein shareholders. The income statement also shows Suzhou investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Suzhou Novoprotein Income Statement Chart
Total Revenue
Total revenue comprises all receipts Suzhou Novoprotein generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Suzhou Novoprotein Scientific minus its cost of goods sold. It is profit before Suzhou Novoprotein operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Suzhou Novoprotein's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Suzhou Novoprotein current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Suzhou Novoprotein Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Suzhou Novoprotein's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 32 M, whereas Tax Provision is projected to grow to (6.3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.8M | 4.0M | 3.6M | 2.9M | Interest Income | 1.4M | 8.5M | 30.5M | 32.0M |
Suzhou Novoprotein income statement Correlations
Click cells to compare fundamentals
Suzhou Novoprotein Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Suzhou Stock
Suzhou Novoprotein Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Suzhou Novoprotein shareholders. The income statement also shows Suzhou investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).